ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2009. On February 25, 2009, CSI completed a reverse merger with Replidyne, Inc. and is now listed on the Nasdaq Global Market® under the symbol “CSII.”
